Overview Research Programs Shared Facilities News & Outreach Technology Transfer Employment About PHRI

 
 
 

  Conference Announcement



 
Dr. Marila Gennaro of PHRI is hosting the conference Biomarkers for Tuberculosis: New Questions, New Tools, which will take place on September 8 - 11, 2013 in Chantilly, VA. The objective of the conference is to integrate knowledge generated through basic, translational, and clinical research that can lead to novel methods and strategies for identifying and assessing biomarkers for tuberculosis. The conference includes plenary sessions featuring invited speakers and speakers selected from among abstracts submitted for poster presentations.

Registration is currently open. The deadline for abstract submission is June 1, 2013.

For the full program and additional information: www.regonline.com/tbconference

To download a PDF copy of the Conference Announcement, please follow this link.



Jim Norris joins PHRI as Director of Community Outreach

 
PHRI is delighted to announce the appointment of Mr. Jim Norris to the newly created position of Director of Community Outreach. Jim brings more than twenty-five years of professional experience to this position, having held positions with the City of Newark, The Newark Public Schools and UMDNJ- New Jersey Medical School. A graduate of Upsala College (Class of 1995 Biology, Pre Med), Jim played professional football with the NY Giants of the National Football League, and then transitioned into a business career focusing on equal employment opportunity /affirmative action. He continued his career as a business developer securing capital for both start-up and established businesses in New Jersey, New York and Georgia. He has a passion for education and helping the “underdog ” and he remains very active within the Greater Newark Community. He serves on various local committees and recently received certification from the Greater Newark Enterprise Corporation for Business Entrepreneurs. Jim will be involved in various PHRI community outreach programs, like the Summer High School Research Internship Program and related educational, health and wellness programs. We welcome Jim to the PHRI family and look forward to working with him.



   
  
 
  04.21.13   China bird flu cases now at 102
  04.21.13   Hilary Koprowski, Who Developed First Live-Virus Polio Vaccine, Dies at 96
  04.18.13   Nature Report: US ricin attacks are more scary than harmful
  03.11.13   CDC issues warning over deadly new SARS-like virus
  02.25.13   NY Daily News: Flu vaccine did poor job in protecting seniors from harshest flu strain
  01.28.13   A CBS News report: "Superbugs: A ticking time bomb"
To view the broadcast, follow this video link
To read the story, visit www.cbsnews.com
  01.24.13   A review: "The Future of Antibiotics and Resistance"
  01.15.13   Associated Press: "CDC: 11 biolab workers infected from 2004-10"


 
  05.18.13   We are very pleased to announce Afia Obeng, who participated in the 2012 PHRI Summer High School Research Intern Program, was awarded a 2013-2014 Project SEED College Scholarship for her freshman year in college by The American Chemical Society’s Project SEED Committee. She is also eligible to apply for a three-year renewal scholarship as she enters her sophomore year.
    
  05.14.13   David Perlin of PHRI contributed to an Inside Health Policy article entitled: "House Lawmakers Seek NIH Insight On Fungal Meningitis Outbreak Response." Select this link to read the artcle.
    
  04.08.13   In this month's update, PHRI Paper Highlights features a study on the role inositol contributes to the development of cryptococcal meningitis, carried out by Dr. Xue's group. For details, please visit PHRI Paper Highlights.
    
  03.05.13   In the March 15 issue of the Journal of Immunology, a study on host mRNA biogenesis in Tuberculosis published by Drs. Pine and Gennaro is highlighted. For details, please visit PHRI Paper Highlights.
    


 


 


     Copyright © 2013 All rights reserved.   PHRI at ICPH 225 Warren St. Newark, NJ 07103-3535 TEL 973 854 3100, FAX 973 854 3101